Histone Acetyltransferases
Histone acetyltransferases (HATs) are a diverse group of enzymes catalyzing a posttranslational modification of acetylation in which the acetyl group from the acetyl-CoA cofactor is transferred to the Nζ nitrogen of the target lysine side chain within histones. Based on the sequence divergence within the HAT domain, HATs is classified into at least five distinct families, including HAT1 family, Gcn5/PCAF family, MYST family, p300/CBP family and Rtt109 family. Despite the sequence divergence, a structurally conserved core region has been identified within each of the protein families, which contains a three-stranded β-sheet with a α—helix corresponding to the A and D regions of the Gcn5-related N-acetyltransferases (GNAT) proteins.
Products for Histone Acetyltransferases
- Cat.No. Product Name Information
-
GC15104
(R)-(+)-Etomoxir sodium salt
(R)(+)Etomoxir
(R)-(+)-Etomoxir sodium salt(Etomoxir) is a small molecule developed for metabolic and cardiovascular disease that exhibits nanomolar potency toward CPT-1a and CPT-1b upon enzymatic conversion to the active inhibitor etomoxiryl CoA (IC50 = 0.01-0.70 µM). -
GC41984
1-Alaninechlamydocin
1-Alaninechalmydocin is a fungal metabolite originally isolated from a Great Lakes-derived Tolypocladium sp.
-
GC42466
4-pentynoyl-Coenzyme A (trifluoroacetate salt)
Click Tag 4pentynoylCoA
Protein acetylation is a reversible, post-translational modification regulated by lysine acetyltransferases and deacetylases and plays a key role in regulating gene expression. -
GC32677
A-485
A-485 is a potent and selective p300/CBP (histone acetyltransferase paralog/CREB binding protein) catalytic inhibitor with IC50 of 60nM for p300 HAT. A-485 inhibits the activity of p300-BHC (bromodomain HAT-C/H3) and CBP-BHC domains with IC50 of 9.8nM and 2.6nM, respectively.
-
GC12917
Acetaminophen
4-Acetamidophenol, APAP, 4'-Hydroxyacetanilide, NSC 3991, NSC 109028, Paracetamol
A COX inhibitor
-
GC64137
Acetaminophen-d3
-
GC10226
Butyrolactone 3
histone acetyltransferase Gcn5 inhibitor
-
GC12733
C646
C646, a potent and selective p300/CBP histone acetyltransferase inhibitor (Ki 400 nM), has been shown to have pleiotropic activity, including neuroprotective, anti-cancer and anti-epithelial-mesenchymal transition (anti-EMT) effects.
-
GC40767
CAY10669
CAY10669 is an inhibitor of the histone acetyltransferase PCAF (p300/CREB-binding protein-associated factor; IC50 = 662 μM), displaying a 2-fold improvement in inhibitory potency over anacardic acid.
-
GC43192
CAY10685
CAY10685 is a cell-active analog of the lysine acetyltransferase inhibitor CPTH2 that contains an alkyne moiety for use in click chemistry reactions.
-
GC68841
CBP/p300-IN-10
CBP/p300-IN-10 is an efficient inhibitor of histone acetyltransferases EP300 and CREBBP, with IC50 values of 26 nM and 39 nM, respectively.
-
GC73365
CBP/p300-IN-20
CBP/p300-IN-20 is a potent and selective p300/CBP inhibitor, with a pIC50 of 10.1 for p300.
-
GC38469
CBP/p300-IN-3
CBP/p300-IN-3, a p300/CBP histone acetyltransferase inhibitor, Compound 6, is sourced from patent WO 2019049061 A1.
-
GC33028
CF53
CF53 is a highly potent, selective and orally active inhibitor of BET protein, with a Ki of <1 nM, Kd of 2.2 nM and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, very selective over non-BET bromodomain-containing proteins. CF53 shows potent anti-tumor activity both in vitro and in vivo.
-
GC11539
CI 976
PD 128042
CI 976 (CI 976) is a potent, orally active, and selective inhibitor of ACAT (acyl coenzyme A:cholesterol acyltransferase) with an IC50s of 73 nM. -
GC62669
CPI-1612
CPI-1612 is a highly potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor with an IC50 of 8.1 nM for EP300 HAT. CPI-1612 has an anticancer activity.
-
GC10382
CPI-637
CBP/EP300 bromodomain inhibitor
-
GC39365
CPTH2
CPTH2 is a potent histone acetyltransferase (HAT) inhibitor. CPTH2 selectively inhibits the acetylation of histone H3 by Gcn5. CPTH2 induces apoptosis and decreases the invasiveness of a clear cell renal carcinoma (ccRCC) cell line through the inhibition of acetyltransferase p300 (KAT3B).
-
GC14428
CPTH2 (hydrochloride)
inhibitor of HAT activity of Gcn5
-
GC43321
CPTH6 (hydrobromide)
CPTH6 is a thiazole derivative that inhibits the lysine acetyltransferase activity of Gcn5 and pCAF but not p300 or CBP.
-
GC19891
CTB
Cholera Toxin B subunit
A potent p300 histone acetyltransferase activator
-
GC14524
CTPB
selective activator of the histone acetyltransferase (HAT) p300
-
GC14787
Curcumin
Indian Saffron, Turmeric yellow
A yellow pigment with diverse biological activities -
GC40226
Curcumin-d6
Curcumin-d6 is intended for use as an internal standard for the quantification of curcumin by GC- or LC-MS.
-
GC63627
DCH36_06
DCH36_06 is a potent and selective p300/CBP inhibitor with IC50s of 0.6 μM and 3.2 μM for p300 and CBP, respectively. DCH36_06 mediated p300/CBP inhibition leading to hypoacetylation on H3K18 in leukemic cells. Anti-tumor activity.
-
GC14490
Donepezil HCl
Donepezil HCl (E2020) is a reversible, selective AChE inhibitor with an IC50 of 6.7 nM for AChE activity.
-
GC73397
DS-9300
DS-9300 is a potent, orally active, selective EP300/CBP HAT inhibitor with an IC50 value of 28 nM.
-
GC31245
EML 425
An inhibitor of p300 and CBP
-
GC13474
Garcinol
Camboginol
Garcinol is an nonspecificity inhibitor of the histone acetyltransferases (HATs) p300 and PCAF .IC50 values are 7μM and 5μM respectively.
-
GC32960
GNE-049
GNE-049 is a highly potent and selective CBP inhibitor with an IC50 of 1.1 nM in TR-FRET assay. GNE-049 also inhibits BRET and BRD4(1) with IC50s of 12 nM and 4200 nM, respectively.
-
GC33212
GNE-207
GNE-207 is a potent, selective and orally bioavailable inhibitor of the bromodomain of CBP, with an IC50 of 1 nM, exhibits a selectively index of?>2500-fold against BRD4 (1). GNE-207 shows excellent CBP potency, with an EC50 of 18 nM for MYC expression in MV-4-11 cells.
-
GC32747
GNE-272
GNE-272 is a potent and selective CBP/EP300 inhibitor with IC50 values of 0.02, 0.03 and 13 μM for CBP, EP300 and BRD4, respectively. GNE-272 is also a selective in vivo probe for CBP/EP300.
-
GC32081
GNE-781
GNE-781 is an orally active, highly potent and selective CBP inhibitor with an IC50 of 0.94 nM in TR-FRET assay. GNE-781 also inhibits BRET and BRD4(1) with IC50s of 6.2 nM and 5100 nM, respectively. GNE-781 displays antitumor activity in an MOLM-16 AML xenograft model.
-
GC31731
GSK 4027
A PCAF/GCN5 bromodomain inhibitor
-
GC30714
GSK4028
GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9 in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.
-
GC12009
HAT Inhibitor II
Histone Acetyltransferase Inhibitor II
HAT Inhibitor II (compound 2c) is a potent, selective and cell permeable p300 histone acetyltransferase inhibitor, with an IC50 of 5 μM. HAT Inhibitor II shows anti-acetylase activity in mammalian cells. -
GC33422
HAT-IN-1
HAT-IN-1 is an inhibitor of HAT, used in the research of cancer.
-
GC43837
Histone H3 Peptide Substrate (1-21)
H3 Peptide
Histone H3 undergoes many modifications including acetylation, methylation, and phosphorylation that are important for regulation of gene transcription. -
GC34078
I-CBP112
I-CBP112 is a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor, that inhibits the CBP/p300 bromodomains, enhances acetylation by p300.
-
GC50721
iP300w
-
GC15836
IWP 12
Inhibitor of Wnt Production-12
Potent inhibitor of Porcupine (PORCN) -
GC73536
JET-209
JET-209 is a potent PROTAC CBP/p300 degrader, with DC50 values of 0.05 nM and 0.2 nM for CBP and p300.
-
GC73483
KAT modulator-1
KAT modulator-1 (Compound 3) is a KAT modulator.
-
GC69326
KAT6-IN-1
KAT6-IN-1 is an effective inhibitor of KAT6 and can be used for cancer research.
-
GC91622
KAT8 Inhibitor 19
Lysine Acetyltransferase 8 Inhibitor 19
KAT8 inhibitor 19 is an inhibitor of lysine acetyltransferase 8 (KAT8; IC50 = 12.1 µM). -
GC45503
L-Moses (hydrochloride)
L-45
-
GC15731
L002
p300/CBP Inhibitor VI, NSC 764414
p300 inhibitor -
GC68405
Lys-CoA TFA
-
GC73460
MC4171
MC4171 (compound 34) is a selective KAT8 inhibitor (IC50=8.1 µM).
-
GC15049
MCB-613
stimulator of steroid receptor coactivator (SRC)
-
GC11439
MG 149
Tip60 HAT inhibitor
HAT inhibitor -
GC33371
MOZ-IN-2
An inhibitor of KAT6A/MOZ
-
GC73228
MS78
MS78 is an acetylation targeting chimera (AceTAC) that acetylates the p53 tumor suppressor protein.
-
GC61841
Naphthol AS-E
Naphthol AS-E is a potent and cell-permeable inhibitor of KIX-KID interaction. Naphthol AS-E directly binds to the KIX domain of CBP (Kd:8.6 ?M), blocks the interaction between the KIX domain and the KID domain of CREB with IC50 of 2.26 ?M. Naphthol AS-E can be used for cancer research.
-
GC18750
NEO2734
EP31670
An orally active dual p300/CBP and BET bromodomain selective inhibitor -
GC62248
NiCur
NiCur is a potent and selective CBP histone acetyltransferase (HAT) inhibitor with an IC50 value of 0.35 μΜ. NiCur, which blocks CBP HAT activity and downregulates p53 activation upon genotoxic stress. NiCur can be used for performing mechanistic studies without affecting the expression of target proteins.
-
GC66049
NSC 694621
NSC 694621 is a potent PCAF inhibitor, with an IC50 of 5.71 μM (PCAF/H31-21). NSC 694621 exhibits good activity of inhibiting the proliferation of cancer cells.
-
GC69597
NSC 694623
NSC 694623 is an effective inhibitor of histone acetyltransferase (HAT), with an IC50 of 15.9 μM against recombinant HAT p300/CBP-associated factor (PCAF). NSC 694623 has anti-proliferative activity in certain cancer cells and can be used for anticancer research.
-
GC14103
NSC228155
EGFR activator
-
GC11972
NU 9056
Selective KAT5 (Tip60) histone acetyltransferase inhibitor (IC50 values are < 2, 60, 36, and >100 μM for KAT5, p300, pCAF and GCN5, respectively).
-
GC69669
PCAF-IN-2
PCAF-IN-2 (compound 17) is an effective inhibitor of PCAF, with an IC50 value of 5.31 μM. PCAF-IN-2 exhibits anti-tumor activity and induces apoptosis and cell cycle arrest at the G2/M phase.
-
GC62247
PF-9363
CTx-648
PF-9363 (CTx-648) is a first-in-class potent and high selective KAT6A/KAT6B inhibitor. PF-9363 can be used for the research of cancer. -
GC36887
PF-CBP1 hydrochloride
PF-CBP1 hydrochloride is a highly selective inhibitor of the CREB binding protein bromodomain (CBP BRD).
-
GC36975
Procyanidin B3
(+)-Catechin-(4α→8)-(+)-catechin, Proanthocyanidin B3, Procyanidol B3
A polyphenol flavonoid dimer with diverse biological activities -
GC63405
PU139
PU139 is a potent pan-histone acetyltransferase (HAT) inhibitor. PU139 blocks the HATs Gcn5, p300/CBP-associated factor (PCAF), CREB (cAMP response element-binding) protein (CBP) and p300 with IC50s of 8.39, 9.74, 2.49 and 5.35 μM, respectively.
-
GC11430
Remodelin
Remodelin is a small molecule inhibitor of N-acetyltransferase 10 (NAT10).Dysregulation of N-acetyltransferase 10 (NAT10) is associated with the development of many types of tumors.
-
GC32880
TPOP146
TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor with Kd values of 134 nM and 5.02 μM for CBP and BRD4.
-
GC41638
TSI-01
TSI-01 is a selective inhibitor of lysophosphatidylcholine acyltransferase 2 (LPCAT2) with IC50 values of 0.47 and 3.02 µM for human LPCAT2 and LPCAT1, respectively.
-
GC45094
TTK21
TTK21 is an activator of CBP/p300 histone acetyltransferase activity.
-
GC10931
VULM 1457
Acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor
-
GC18154
WM-1119
A highly potent, selective KAT6A/B inhibitor
-
GC62104
WM-3835
WM-3835 is a potent and high-specific HBO1 (KAT7 or MYST2) inhibitor and binds directly to the acetyl-CoA binding site of HBO1 33. WM-3835 activates apoptosis while inhibits osteosarcoma (OS) cell proliferation, migration and invasion. WM-3835 has antitumor activity and potently inhibits pOS-1 xenograft growth in mice.
-
GC18153
WM-8014
WM8014,WM 8014
Inhibitor for KAT6A (MOZ) and KAT6B (MORF/QKF), anticancer
-
GC31099
YF-2
A HAT activator
-
GC12934
YM 750
Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor